ANKRD11 antibody (N-Term)
Quick Overview for ANKRD11 antibody (N-Term) (ABIN629618)
Target
See all ANKRD11 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- ANKRD11 antibody was raised against the N terminal of ANKRD11
-
Purification
- Purified
-
Immunogen
- ANKRD11 antibody was raised using the N terminal of ANKRD11 corresponding to a region with amino acids KRKLPFTAGANGEQKDSDTEKQGPERKRIKKEPVTRKAGLLFGMGLSGIR
-
-
-
-
Application Notes
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
ANKRD11 Blocking Peptide, (ABIN940013), is also available for use as a blocking control in assays to test for specificity of this ANKRD11 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ANKRD11 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
-
Alternative Name
- ANKRD11
-
Background
- ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
-
Molecular Weight
- 298 kDa (MW of target protein)
Target
-